Literature DB >> 12236591

Purification and characterization of a potent hemolytic toxin with phospholipase A2 activity from the venom of Indian Russell's viper.

Amit K Chakraborty1, Robert H Hall, Asoke C Ghose.   

Abstract

A potent toxin with phospholipase A2 (PLA2) and hemolytic activity in vitro was purified from the Russell's viper venom of eastern India (RVV-EI). The purified protein (RVV-PFIIc') of 15.3 kDa molecular weight, and a lethal toxicity dose (LD50i.p.) of 0.1 mg/kg body weight, was the most toxic PLA2 so far reported from the Indian subcontinent. The material also possessed anticoagulant activity as it enhanced the prothrombin induced plasma clotting time in vitro. The PLA2 toxin (RVV-PFIIc') was shown to be different from other PLA2s of RVV in respect to one or more of these parameters e.g. molecular weight, isoelectric pH, in vivo toxicity, specific activity of the enzyme and certain other biological activities. The first 19 amino terminal sequence (NLFQFAEMIVKMTGKEAVH) of RVV-PFIIc' showed variable degree of homology (42.1-94.7%) with those of other RVV-PLA2s described in the literature. Antisera raised against RVV-EI or RVV-PFIIc', though completely neutralized the in vivo lethal toxicity of RVV-EI or RVV-PFIIc', failed to inhibit their PLA2 activity in vitro thereby suggesting that in vivo toxicity and in vitro activity of the enzyme may not be directly related. Apart from RVV-PFIIc', at least two other PLA2 isozymes were found to be present in RVV-EI that were distinct from RVV-PFIIc' in respect to their molecular, biological as well as serological properties. The significance of these and related data in antivenom therapy is discussed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12236591     DOI: 10.1023/a:1016591318855

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  24 in total

Review 1.  Venoms, antivenoms and immunotherapy.

Authors:  J P Chippaux; M Goyffon
Journal:  Toxicon       Date:  1998-06       Impact factor: 3.033

Review 2.  Snake venom components and their cross-reactivity: a review.

Authors:  B J Berger; A R Bhatti
Journal:  Biochem Cell Biol       Date:  1989-09       Impact factor: 3.626

3.  Proteolytic, hemorrhagic and hemolytic activities of snake venoms.

Authors:  J G Soto; J C Perez; S A Minton
Journal:  Toxicon       Date:  1988       Impact factor: 3.033

4.  Chromatofocusing.

Authors:  L Giri
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

Review 5.  The three-dimensional structures of two toxins from snake venom throw light on the anticoagulant and neurotoxic sites of phospholipase A2.

Authors:  E Carredano; B Westerlund; B Persson; M Saarinen; S Ramaswamy; D Eaker; H Eklund
Journal:  Toxicon       Date:  1998-01       Impact factor: 3.033

6.  Purification and characterization of a major phospholipase A2 from Russell's viper (Vipera russelli) venom.

Authors:  S Kasturi; T V Gowda
Journal:  Toxicon       Date:  1989       Impact factor: 3.033

7.  Progress in the characterization of venoms and standardization of antivenoms.

Authors: 
Journal:  WHO Offset Publ       Date:  1981

8.  Isolation and pharmacological properties of phospholipases A2 from Vipera russelli (Russell's viper) snake venom.

Authors:  H C Huang; C Y Lee
Journal:  Toxicon       Date:  1984       Impact factor: 3.033

9.  Characterization and molecular cloning of neurotoxic phospholipases A2 from Taiwan viper (Vipera russelli formosensis).

Authors:  Y M Wang; P J Lu; C L Ho; I H Tsai
Journal:  Eur J Biochem       Date:  1992-10-15

10.  A platelet function inhibitor purified from Vipera russelli siamensis (Smith) snake venom.

Authors:  Y S Li; K F Liu; Q C Wang; Y L Ran; G C Tu
Journal:  Toxicon       Date:  1985       Impact factor: 3.033

View more
  3 in total

1.  Purification of a phospholipase A(2) from Daboia russelii siamensis venom with anticancer effects.

Authors:  Suchitra Khunsap; Narumol Pakmanee; Orawan Khow; Lawan Chanhome; Visith Sitprija; Montamas Suntravat; Sara E Lucena; John C Perez; Elda E Sánchez
Journal:  J Venom Res       Date:  2011-10-22

Review 2.  Snake Venom PLA2, a Promising Target for Broad-Spectrum Antivenom Drug Development.

Authors:  Huixiang Xiao; Hong Pan; Keren Liao; Mengxue Yang; Chunhong Huang
Journal:  Biomed Res Int       Date:  2017-11-29       Impact factor: 3.411

3.  A Biochemical and Pharmacological Characterization of Phospholipase A2 and Metalloproteinase Fractions from Eastern Russell's Viper (Daboia siamensis) Venom: Two Major Components Associated with Acute Kidney Injury.

Authors:  Janeyuth Chaisakul; Orawan Khow; Kulachet Wiwatwarayos; Muhamad Rusdi Ahmad Rusmili; Watcharamon Prasert; Iekhsan Othman; Syafiq Asnawi Zainal Abidin; Mongkon Charoenpitakchai; Wayne C Hodgson; Lawan Chanhome; Narongsak Chaiyabutr
Journal:  Toxins (Basel)       Date:  2021-07-26       Impact factor: 4.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.